{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:54:31Z","timestamp":1771674871467,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>Erosive oral lichen planus (EOLP) is a chronic inflammatory disease of the oral mucosa causing significant pain and impairment of the quality of life. No immediate and definitive cure is available, especially in its chronic and most recalcitrant forms. The objective of this study was to evaluate the efficacy of methotrexate treatment in EOLP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>A prospective open trial of oral methotrexate 15\u00a0mg QWK in 18 patients with EOLP (clinically and histopathologically confirmed) unresponsive to at least one previous topical or systemic medication. Duration: Twelve weeks followed by twelve weeks of follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Partial response or better was achieved in 15 (83.3\u00a0%) patients. A statistically significant reduction in Thongprasom scale score was observed (mean value 5 at baseline, 3.08 \u00b1\u00a01.11 at week 12, 2.94 \u00b1\u00a00.97 at week 24, P value\u00a0&lt;\u00a00.001). A statistically significant reduction was noted in the pain visual analogue scale (mean value 6.55 \u00b1\u00a02.33 at baseline, 2.46 \u00b1\u00a02.18 at week 12, 2.29 \u00b1\u00a01.93 at week 24, P\u00a0value\u00a0&lt;\u00a00.001). Adverse events occurred in four (22.2\u00a0%) patients, requiring discontinuation of treatment in one patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Methotrexate is a valuable therapeutic option in longstanding recalcitrant EOLP, particularly with respect to the improvement of subjective symptoms. Randomized controlled trials are required.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ddg.12636","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T06:29:30Z","timestamp":1457936970000},"page":"286-293","source":"Crossref","is-referenced-by-count":19,"title":["Treatment of erosive oral lichen planus with methotrexate"],"prefix":"10.1111","volume":"14","author":[{"given":"Vahideh","family":"Lajevardi","sequence":"first","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Zahra","family":"Ghodsi","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hallaji","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Shafiei","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessa","family":"Aghazadeh","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Akbari","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,3,12]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2008.00662.x"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120452"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.06.076"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(96)80439-2"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.4172\/2376-032X.1000142"},{"key":"e_1_2_5_7_1","first-page":"CD008092","article-title":"Interventions for erosive lichen planus affecting mucosal sites","volume":"2","author":"Cheng S","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.4.511"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar419"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155502753600966"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2008.00472.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1992.tb00974.x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.8.729"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.6.2441"},{"key":"e_1_2_5_15_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4049\/jimmunol.154.1.326","article-title":"Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins","volume":"154","author":"Firestein GS","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_16_1","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.4049\/jimmunol.162.6.3607","article-title":"IFN\u2010gamma up\u2010regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation","volume":"162","author":"Xaus J","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/742826"},{"issue":"3","key":"e_1_2_5_18_1","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian H","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.054"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04654.x"},{"issue":"10","key":"e_1_2_5_21_1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/ddg.12141","article-title":"Individualizing treatment and choice of medication in lichen planus: a step by step approach","volume":"11","author":"Manousaridis I","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"e_1_2_5_22_1","first-page":"645","article-title":"Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis","volume":"31","author":"Hoekstra M","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10766"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.12636","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.12636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:39:57Z","timestamp":1696336797000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.12636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1111\/ddg.12636"],"URL":"https:\/\/doi.org\/10.1111\/ddg.12636","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}